Potentially promising biosimilar appears in the pipeline

The U.S. Food and Drug Administration (FDA) has approved Cyltezo (adalimumab-adbm), a biosimilar to Humira (adalimumab), for the treatment of multiple chronic inflammatory diseases, including psoriasis and psoriatic arthritis.

Cyltezo is indicated for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. 

Cyltezo is also indicated, alone or in combination with traditional disease-modifying antirheumatic drugs, or DMARDs, for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis.

The biosimilar, which is manufactured by Boehringer Ingelheim Pharmaceuticals, is administered with a pre-filled syringe. The company is also seeking approval for an auto-injector.

Cyltezo is not commercially available at this time due to pending litigation.

Read more about biosimilars.

 


Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

Illustration of diet and exercise icons
NPF's medical board publishes a paper on diet recommendations for people...
Hurricane Florence
Get the latest information about health insurance and prescription drugs if you...
Ready to lace up with Team NPF? Here are 7 simple ways to help you bulletproof...
People at table having policy discussion
Expanding access to care starts in the boardroom. Here’s how we take it on the...
Steven Larky riding bike for Team NPF
Three successful Team NPF volunteers reveal their cash-maximizing strategies.
Psoriasis unexpectedly brings a mother and daughter closer together — and...
Make the transition to the classroom easier with free resources for kids and...
A lack of knowledge and resources was no barrier to Jessica Houston’s quest to...
An annual public policy forum for everyone from lawmakers to educators gives us...